Related Experiment Video
Updated: Feb 1, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Impact of genetic polymorphisms on platelet function and response to anti platelet drugs
Teresa Strisciuglio1, Danilo Franco1, Giuseppe Di Gioia1
1Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Insights
Cardiovascular genomics identifies genes influencing coronary artery disease (CAD) susceptibility. Understanding genetic variations in platelet function and anti-platelet drug response is crucial for treating CAD patients.
Area of Science:
- Cardiovascular genomics
- Platelet biology
- Pharmacogenomics
Background:
- Coronary artery disease (CAD) susceptibility is linked to polymorphic genes.
- Platelet activation, aggregation, and drug response exhibit heritable variability.
- Genetic factors influence CAD risk and treatment outcomes, especially after percutaneous coronary intervention (PCI).
Purpose of the Study:
- To explore the role of cardiovascular genomics in identifying genes associated with CAD.
- To investigate the genetic basis of platelet hyper-reactivity and response to anti-platelet therapies.
- To highlight the shift towards advanced genetic analysis techniques in CAD research.
Main Methods:
- Identification of polymorphic genes related to cardiovascular disease.
- Analysis of genes involved in platelet function and response to anti-platelet drugs.
- Application of advanced genetic techniques including genome-wide association (GWAS) studies and miRNA-mRNA expression profiling.
Main Results:
- Genes influencing platelet activation and aggregation are key in CAD predisposition.
- Heritable hyper-reactivity of platelets affects drug response.
- Advanced genomic techniques offer new insights into CAD genetics.
Conclusions:
- Cardiovascular genomics is essential for understanding CAD susceptibility.
- Genetic insights into platelet function and drug response can personalize CAD treatment.
- Genome-wide association studies and expression profiling are advancing the field.
Abstract:
Cardiovascular genomic consists in the identification of polymorphic genes responsible for the susceptibility to cardiovascular disease including coronary artery disease (CAD). Genes involved in platelet activation and aggregation play a key role in the predisposition to CAD. A considerable inter-variability of platelet response to agonists and to drugs exists and in particular the hyper-reactivity phenotype seems to be heritable. Besides glycoproteins and receptors expressed on platelets surface whose mutations significantly impact on platelet function, moreover researchers in the last decades have paid great attention to the genes involved in the response to anti-platelet drugs, considering their pivotal role in the treatment and outcomes of CAD patients especially those undergoing PCI. With the outbreak of advanced techniques developed to analyse human genetic footprints, researchers nowadays have shifted from genetic linkage analysis and a candidate gene approach toward genome-wide association (GWAS) studies and the analysis of miRNA-mRNA expression profiles.
More Related Videos
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Factors Affecting Drug Response: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Impact of Groups on Groups